has_Ingredient
has_MoA
has_PE
drug associated with AE in adult
drug associated with AE in pediatric
used to treat disease
HIV Protease Inhibitors [MoA]
Increased Immunologically Active Molecule Activity [PE]
atazanavir [Chemical/Ingredient]
A [Preparations]
ATAZANAVIR
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021567s026lbl.pdf
4024316
ATAZANAVIR
343047
Atazanavir
Active
<VANDF_Record>50.6^3890^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>3890</VA_IEN>
Ingredient
<VANDF_Record>50.416^4656^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>4656</VA_IEN>
N0000022320
C1145759
C53848
human immunodeficiency virus infectious disease
pain in extremity AE
wheezing AE
nasal congestion AE
oropharyngeal pain AE
rhinorrhea AE
fever AE
rash AE
myalgia AE
headache AE
dizziness AE
edema limbs AE
cough AE
abdominal pain AE
jaundice AE
depression AE
nausea AE
vomiting AE
diarrhea AE
insomnia AE